THYME AND CARVACROLL Nanoparticle Effect on Fungi

Effect of Thyme and Carvacroll Nanoparticles on Aspergillus Fumigatus Isolate From Intensive Care Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04431804

Enrollment

210

Registered

2020-06-16

Start date

2020-06-11

Completion date

2020-09-30

Last updated

2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspergillosis

Brief summary

Invasive Aspergillosis (IA) has increasingly been recognized as an emerging disease of non-neutropenic patients and in patients admitted to the ICU, even in the absence of an apparent predisposing immune-deficiency, with incidence ranges from 0.3% to 5.8% with an overall mortality rate exceeding 80%.

Interventions

OTHERsilver nanoparticle

fungicidal effect of silver nanoparticles on aspergillus isolates

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* intensive care patients

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
fungicidal effect of silver nanoparticles on aspergillus fumigatus	24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026